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ABSTRACT
One of the main causes of neurodegenerative diseases is aggregation of amyloid
proteins that are toxic to the neurons. Proteins like amyloid-β (Aβ) and α-syneuclein (αsyn) form hallmark aggregate lesions that contribute to pathological processes in the
brain in Alzheimer and Parkinson’s patients, respectively. Recent ground-breaking
studies have suggested a link between the microbiota of the gut and neurodegenerative
diseases, called the “gut-brain axis.” It has been long known that the protein, CsgA found
in many enteric bacteria, forms amyloid fibers of its own called Curli. Curli fibrils are a
structural component of bacterial colonies and maintain the integrity of biofilms, making
CsgA a “functional amyloid protein.” In this study, the hypothesis that CsgA and Aβ
interact directly with one another to support the suggestion of the gut-brain axis is
investigated. To do so, a plasmid containing CsgA is recombinantly expressed in E. coli
cells and then purified in large scales for further testing of its interactions in-vitro.
Various biophysical methods were used to isolate the CsgA protein in pure form. Once
isolated, the interactions of CsgA with Aβ and other extracellular components reveal that
CsgA inhibits the aggregation of Aβ, but Aβ seems to have no effect on the aggregation
of CsgA. CsgA aggregation was also observed to be unaffected by the presence of NaCl.

Keywords: protein aggregation, neurodegenerative disease, brain-gut axis, amyloid-β,
Curli
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INTRODUCTION
1.1 Neurodegenerative diseases and the brain-gut axis
Neurodegenerative diseases are described as diseases that affect the central
nervous system and drive cognitive decline of victims in late adulthood. Of the several
types of neurodegenerative diseases, Alzheimer disease (AD) is the most common,
leading to neuronal decline that results in fatality.1 One of the hallmark lesions of AD is
the presence of extracellular aggregates of amyloid-β protein (Aβ).2 Aβ is an intrinsically
disordered protein which is prone to abberant aggregation both without and upon
interaction with multiple partners.1
Specifically, it has been found that low molecular weight aggregates of Aβ
protein generated by anionic lipid micelles can drive neuronal decline in AD inflicted
mice brains.3 Aggregation of Aβ has also been influenced by another protein, α-synuclein
(α-Syn), involved in Parkinson’s disease (PD).4 These reports indicate that multiple
players are involved in AD-related neurodegeneration that potentially give rise to the
onset of several phenotypes and clinical sub-types. While there are many existing
hypotheses for various phenotypes in AD, one of the recent ones is the involvement of
bacterial amyloids in interacting with proteins like α-Syn and Aβ leading to
neurodegenerative diseases.5, 6, 7
Bacteria in human gut microbiomes are generally known to aid the digestive
system in the breakdown of foods into nutrients that can be absorbed by the body.
Interestingly enough, gut microbiota affect much more than the body’s digestive system;
they also affect the nervous system of the body, known as the gut-brain axis. The gutbrain axis was coined to acknowledge the steady, bidirectional communication that
1

occurs between the digestive tract and the central nervous system.8 This communication
is thought to occur by way of metabolic activity of endosymbiotic microbes in the gut:
by-products of these microbes increase intestinal permeability allowing neurotransmitter
production and absorption to be influenced by these gut processes.8

1.2 Curli CsgA
In bacterial cells such as E. coli, amyloid proteins are formed to help them
produce biofilms as a method of protection against extracellular environmental factors;
however, these amyloidogenic proteins can be transported to the brain through the gutbrain axis and modulate the aggregation of other proteins to initiate various
neurodegenerative diseases.5, 6 An interesting gut bacterial protein, CsgA, was discovered
in the 1980s that displayed the ability to form amyloid fibrils called Curli that aid in
biofilm formation.9 There is a void in the knowledge of how exactly these protein
aggregates form and interact with other cellular components of the body to induce
toxicity and neurodegeneration.10 This study is an ongoing research project that aims to
further understand the Aβ aggregations induced by CsgA.To observe the interaction invitro among the aforementioned proteins, they needed to be recombinantly expressed
within the bacterial cells and purified via various biochemical techniques in large scales.

1.3 Rationale and hypotheses
To uncover the mechanistic link between the gut microbiota and
neurodegeneration, we hypothesize that CsgA amyloids cross-interact with Aβ that is also
present in the intestines to promote toxic oligomers of the latter. While Aβ recombinant
2

expression and purification has been well-established in the laboratory, this project is
focused on recombinant expression and purification of CsgA protein in E. coli cells.
Once expressed and purified, the interactions and behaviors of CsgA under various
conditions will be observed. It is hypothesized that CsgA will show some effect upon
interactions with other amyloidogenic proteins such as Aβ and that aggregation of CsgA
will be affected by interaction with other cellular components, providing evidence for the
gut-brain axis.

3

MATERIALS AND METHODS
2.1 Materials
CsgA plasmid was a generous gift from Chapman lab at the University of
Michigan. The C8 Zorbax semi-prep high performance liquid chromatography (HPLC)
column was purchased from Agilent. Routine lab chemicals were purchased from SigmaAldrich and Thermofisher. BL21-DE3 and DH5α competent cells were grown and
transformed with CsgA plasmid. Ni-NTA column was used in addition to Tris base,
imidazole washes, guanidine hydrochloride, and strip buffer.

2.2 Methods
Plasmid Isolation from DH5α cells. A 2 μL aliquot of CsgA plasmid was added
to 10 μL of DH5α competent cells and allowed to sit for 30 minutes at room temperature.
The cells and plasmid were then heat-shocked for 20 seconds and immediately placed in
ice for an additional two minutes. Next, 200 μL of SOC media was added to the mixture,
and it was allowed to agitate for one hour at 37 ̊ C. The cells were then plated in amounts
of 125 μL (i), 50 μL (ii), and 25 μL (iii) and incubated overnight.
Colony numbers 1-6 were chosen and placed into media tubes containing 2 mL of
LB ampicillin broth each. The tubes were left to incubate overnight for plasmid
extraction the following day. The DH5α cells were centrifuged in 4-6 mL aliquots at
18,000 RCF for 2 minutes. The cell pellet was then resuspended in 600 mL of H2O. 100
μL of Zymo 7x lysis buffer and 350 μL of neutralization buffer were added and mixed.
The cell solution was centrifuged again at 13,000 RCF for 10 minutes, and the
supernatant was added to the Zymo column. The Zymo column was placed in a collection
4

tube, centrifuged at 13,000 RCF for 1 minute, and the flow through was discarded. 200
μL of Eudo-wash buffer were added and then the Zymo column was centrifuged again for
1 minute. 400 μL of Zyppy wash buffer were added to the column next and centrifuged
for 1 minute. The Zymo column was transferred to a clean Eppendorf tube and 20 μL of
warm H2O (~ 40 ̊ C) were added to the column matrix and incubated at room temperature
for 20 minutes. The tube was centrifuged for a last time at 10,000 RCF for 2 minutes to
elute the DNA for imaging. The plasmid was stored at -20 ̊ C for future use.
Transformation and growth of BL21-DE3 cells. A 2 μL aliquot of CsgA plasmid
was added to 10 μL of BL21-DE3 competent cells and allowed to sit for 30 minutes at
room temperature. The cells and plasmid were then heat-shocked for 20 seconds and
immediately placed in ice for an additional two minutes. Then, 200 μL of SOC media
were added to the mixture, and it was allowed to agitate for one hour at 37 ̊ C. The cells
were then plated on ampicillin agarose plates using sterile glass beads in amounts of 125
μL (i), 50 μL (ii), and 25 μL (iii) and incubated overnight at 37 ̊ C. There were 2 sets of
transformations performed: CsgA I (i, ii, iii) and CsgA II (i, ii, iii). An aliquot of the
transformed BL21-DE3 cells were incubated overnight in 100 mL of LB media broth
with 100 μL of Ampicillin at 37 ̊ C in the shaker. The following day, 1 mL each of the
overnight cell culture was added to two autoclaved flasks containing 1 L of LB broth
media each. The flasks were then placed in the shaking incubator at 37 ̊ C, and the optical
density (OD) was recorded in 15-minute intervals. The cells in each flask were induced
with 1 mL of isopropyl b-D1-thiogalactopyranoside (IPTG) once the OD reading
measured between 0.6 and 0.8 OD600 and then left to incubate in the shaker at 37 ̊ C
overnight. The media was then added to four 500 mL containers, and the cells were
5

centrifuged for 20 minutes at 10,000 RCF. The supernatant was discarded and the
containers with the remaining pellets were stored in the -20 ̊ C freezer.
Ni(II)-affinity chromatography. Stored BL21-DE3 cells from the -20 ̊ C were
obtained in the amount of 1 L. The cells were resuspended in 50 mL of 20 mM Tris
buffer + 1 mM EDTA (pH 7.2) and then sonicated for 12 cycles of 30 seconds on/1
minute off at 18/20 power. The sonicated cells were then centrifuged at 20,000 RCF for
20 minutes. The supernatant (supernatant I) from the centrifugation was discarded, and
the pellet (pellet I) was resuspended in 6 M guanidine hydrochloride to lyse the inclusion
bodies that contain the protein of interest. After resuspension, pellet I was sonicated again
for 10 cycles of 30 seconds on/1 minute off at 18/20 power. The lysate of pellet I was
centrifuged once more at 20,000 RCF for 20 minutes. The supernatant (supernatant II)
was collected, and the pellet (pellet II) was discarded.
The Ni-NTA column was equilibrated with 10 mL of 200 mM NiSO4 and 8 mL of
guanidine hydrochloride. Supernatant II was added to the column containing Ni-NTA
beads. The column was inverted several times to suspend the beads in the supernatant.
The suspended Ni-NTA beads in supernatant II were allowed to mix overnight at 4 ̊ C on
a shaker to allow the 6 His-tag of CsgA to bind to the Ni(II) in the beads. The next day,
supernatant II containing the Ni-NTA beads was run through the column, and the flowthrough was collected. The column was then washed with 50 mL of 20 mM Tris buffer
(pH 7.2) to wash out any unbound contaminants. Washes of 50 mL of 50 mM imidazole
and 30 mL of 100 mM imidazole were run to wash out any non-specifically bound
proteins. To elute the protein of interest, 6 mL of 300mM imidazole were run through the
column to cleave the bond between the protein and the Ni-NTA beads. The 6 mL elution
6

was added to clean Eppendorf tubes in 1 mL aliquots each and stored in the -80 ̊ C
freezer.
High Performance Liquid Chromatography (HPLC). The C18 Phenomenex
semi-prep HPLC column was prepped and equilibrated with 95% nanopure H2O and 5%
acetonitrile containing 0.01% TFA. Equilibrated column was heated to ~ 60 ̊ C and a 1
mL aliquot of CsgA (500 mL/6) was loaded to the HPLC column. HPLC purification was
done at 60 ̊ C with increasing acetonitrile gradient. Protein samples were collected in
acetonitrile-water and further characterized and lyophilized for later use.
Gel electrophoresis and immunoblotting. Prior to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS PAGE), 1X Laemmli loading buffer (1% SDS)
was added to the samples before loading them into 4%-20% Bis-Tris Bio-Rad TGX gels
without heating. For fragment molecular weight comparison, pre-stained molecular
weight markers (Novex Sharp Protein Standard, Life Technologies) were run in parallel.
Following PAGE, gels were immunoblotted onto a 0.2 µM nitrocellulose membrane
(Bio-Rad) and boiled in 1X PBS in a microwave oven for 1 minute. The immunoblot was
then blocked in 1X PBS containing 5% nonfat dry milk and 1% Tween 20 for 1.5 hours
at 25 ºC before being probed overnight with Aβ-specific Ab5 monoclonal antibody
(1:6000 dilution) at 4 ºC. Anti-mouse, horseradish peroxidase-conjugated secondary
antibody (1:6000 dilution) was then used to probe the immunoblot for 1.5 hours at 25 ºC.
Blots were then imaged with a Super SignalTM West Pico Chemiluminescent Substrate
kit (Thermo Fisher Scientific).
MALDI-MS spectroscopy. The Bruker Daltonics Microflex LT/SH TOF-MS
system was used for matrix assisted laser desorption/ionization (MALDI) mass
7

spectrometry. The system was calibrated using the Bruker Protein Calibration Standard I
(Bruker Daltonics). A 2 μL aliquot of sinapinic acid (SA) matrix in saturated AcN and
H2O and a 2 μL aliquot of HPLC fraction 21 were added to a clean Eppendorf tube and
mixed well. The 4 μL solution was then spotted onto a Bruker MSP 96 MicroScout
Target with plate and allowed to dry at 37 ̊ C for 15 minutes before collecting spectra.
Circular dichroism (CD) spectroscopy. A Jasco J-815 spectropolarimeter was
used to collect UV CD spectra of 10-25 μM of CsgA at 260-190 nm. An aliquot of CsgA
protein was added to a 1 mm pathlength quartz cuvette and 6-16 UV scans were
conducted at 50 nm/min with an 8 second response time, 1 nm bandwidth, and 0.1 nm
data pitch. The Jasco spectrum analysis program was used to average the data from each
spectral scan for analysis.
Aggregation of CsgA. Aggregation kinetics of CsgA was monitored by
thioflavin-T (ThT) fluorescence at 37 º C in a BioTek Synergy 96 well plate reader. The
reactions with CsgA were carried out with Aβ monomer (10 µM) and various
concentrations of CsgA in the presence of 50 mM NaCl & 50 µM ThT in 20mM Tris
buffer (pH 8.0). Each reaction was transferred in 200 µL aliquots to a Corning 96-well
plate (black plates) for aggregation kinetics. Samples were excited at 452 nm, and ThT
fluorescence was obtained with an emission at 485 nm at every 10 minutes at 37ºC with
shaking.

8

RESULTS
3.1 Plasmid isolation from DH5α cells
The concentration of the extracted plasmid was measured on a nanodrop as 151.9
ng/μL with 1.81 A260/A280, and 1.78 A260/A230. The extracted plasmid was stored in the 20 ̊ C freezer for further use.

3.2 Transformation of BL21DE3 cells
After overnight incubation of the
two sets of transformations, well-isolated
colonies of cells were selected (Fig. 1),
labelled, and streaked on second agar
plates, and stored at 4 ̊ C for further use.

3.3 Expression of CsgA colonies
Cell stocks were made from the

Figure 1: A plate of ampicillin-containing CsgA
BL21-DE3 cells is shown. Colonies are marked for
picking on the underside of the plate.

colonies and the expression levels of the
protein were analyzed. The cells were lysed

Figure 1: A plate of ampicillin-containing CsgA
BL21-DE3 cells is shown. Colonies are marked for
picking on the underside of the plate.

and loaded on to a 10% tris-glycine gel for
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electrophoresis. The gels developed by

160
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colonies between 13-22 expressed the CsgA

10
3.5

protein as indicated by the band in each lane
at 14 kDa (Fig. 2).
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3.4 Optimized Purification of CsgA
The purification protocol involving the lysis of the inclusion bodies via a second
resuspension and sonication from the

260
160
110
80
60
50
40
30
kDa 20

pellet obtained from the initial
centrifugation was optimal for CsgA
purification yield. Gels developed

15

with silver stain techniques revealed a

10
3.5

band at 14 kDa in the 300 mM lane
B

50
mM

100
mM

300
mM

S

(Fig. 3), indicating the presence of

Figure 3: This image shows an SDS PAGE gel from the
final optimized purification protocol developed with
silver stain.

CsgA with minimal contaminants as
well as minimal protein elution in the

following lane labelled “S” containing the strip buffer.

3.5 Purification Troubleshooting Processes
Use of SpinTrap G-25 desalting columns. The initial purification protocol for
CsgA involved resuspending the stored cells in 6 M guanidine hydrochloride, sonicating
the resuspended cells, collecting the supernatant, and discarding the pellet. The
supernatant was allowed to mix with the Ni-NTA beads for 1 hour at 4 ̊ C before being
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run through the Ni-NTA column. When the
0.12

Absorption

UV absorbance of the protein was observed,
a peak at 250 nm instead of 280 nm
suggested that the protein may have
precipitated or was strongly bound to DNA

0.1
0.08
0.06
0.04
240

(Fig. 4). This initial method of purification

290

Wavelength (nm)

yielded a very small concentration of
Figure 4: This graph of UV spectroscopy is
representative of the initial purification methods
using desalting methods. A peak at 250 nm
instead of 280 nm (indicative of CsgA) is
observed.

protein (196 μg/L of cells) even after
desalting the 200 mM eluate with SpinTrap
G-25 desalting columns.

Use of 10 kDa Amicon Ultra

0.035

Absorption

0.03

MWCO filter. Later modifications of the

0.025

purification protocol added filtration of the

0.02
0.015

elution through a 10 kDa Amicon Ultra

0.01
0.005
260

280

300

320

340

Wavelength (nm)

Figure 5: This graph of UV spectroscopy is
representative of early purification methods using
a 10 kDa Amicon Ultra centrifugal filter. A peak at
275 nm instead of 280 nm (indicative of CsgA) is
observed.

molecular weight cut off (MWCO)
centrifugal filter. The Ni-NTA column was
washed with 10 mL of 200 mM imidazole
buffer to elute the Ni-NTA bound protein.
The eluate was added to a 30 kDa Amicon

Ultra MWCO centrifugal filter to remove any remaining tags that were bound to the
protein. A 10 kDa Amicon Ultra MWCO centrifugal filter was subsequently used to
remove any smaller fragment residues. The protein was then dialyzed with 20 mM Tris
buffer (pH 7.2) using an 8 kDa membrane. When the UV absorbance of the protein was
11

imaged (Fig. 5), a peak at 275 nm was observed, and visible precipitate was observed on
the Amicon filter after centrifugation. The
calculated concentration of protein increased from
the previous protocol (460 μg/L of cells); however,
it was still lower than optimal for use in further
experiments. The SDS PAGE gel developed with
silver stain (Fig. 6) showed a prominent band just at
14 kDa in the 10 kDa lane suggesting presence of
CsgA protein; other bands suggest the presence of
higher molecular weight aggregates and other non-

Figure 6: This SDS PAGE gel
developed with silver stain represents
the modified purification protocol that
utilizes a 10 kDa Amicon Ultra MWCO
centrifugal filter.

specifically Ni-NTA bound proteins that eluted with
the 200 mM elution.

Absorption

Lysing of inclusion bodies. When the UV absorbance of the protein was observed
0.06
0.05

(Fig. 7) following purification using

0.04
0.03

techniques to lyse inclusion bodies, a peak

0.02
0.01

was seen at 280 nm, and the calculated

0
-0.01

protein concentration yield (892.8 μg/L of

-0.02
260

280

300

320

340

Wavelength (nm)

Figure 7: This graph of UV spectroscopy is
representative of the optimized purification
protocol that allowed for the lysis of inclusion
bodies. The peak at 280 nm is indicative of the
presence of CsgA.

cells) was almost doubled from the
previous protocol. Gel electrophoresis run
on the purifications that lysed the inclusion
bodies were run and stained with silver
stain techniques. In the lane labelled “E”
12

for final elution in 300 mM imidazole wash (Fig. 8), a
band at 14 kDa is observed that represents the elution of
the CsgA protein. It can also be observed that some

260
160
110
80
60
50

contaminants were eluted in the 50 mM imidazole wash
lane contributing to the successful final elution of protein.

40
30
20
15
10
3.5
S

3.6 Confirmation of CsgA Purification
After collecting the elution sample from the
optimized purification protocol, HPLC was run (Fig. 9)

E

50
mM

B

Figure 8: This SDS-PAGE gel
is one of many developed with
silver staining techniques that
depict CsgA protein yield in
the second lane labelled “E”
for elution in 300 mM
imidazole wash.

and an SDS PAGE gel was developed with silver stain in
which the band at
14 kDa in the
fraction 21 (F21)
lane corresponds to
the presence of
Figure 9: In this HPLC graph, the peak
at 14 minutes indicates the peak for
fraction 21.

CsgA (Fig 10). A
dot blot (Fig. 11)

and MALDI mass spectrometry (Fig. 12) were performed

Figure 10: In this HPLC SDS
PAGE gel developed with
silver stain, the band at 14 kDa
in fraction 21 (F21) indicates
the presence of CsgA.

on HPLC fractions 21, 22, and 23. Analysis of the mass spectrometry data from HPLC
fractions 21, 23, and 23 revealed that fraction 21 contained the protein of interest
indicated by the peak with the molecular weight just under 4,000 kDa (Fig. 12). HPLC
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fraction 21 was calculated to contain 13.9 kDa of
CsgA protein. Fraction 21 was then lyophilized in
cold lyophilizer and resuspended in 20 mM Tris
buffer (pH 7.2).
Biophysical characterization. Circular
Figure 11: This image depicts the dot
blot of HPLC fractions 21, 22, and 23.

dichroism (CD) of HPLC fraction 21 revealed that the
protein possessed a random coil structure indicated by

a minima peak at 200 nm (Fig. 13). ThT (Thioflavin-T) fluorescence analysis was done to
analyze the aggregation of CsgA, as it is known to form amyloids. Therefore, 25 μM of
protein both with and without the presence of NaCl were analyzed at 37 º C. CsgA

Figure 12: In this figure, mass spectrometry peaks of HPLC fraction 21, 22, and 23 are shown. The blue peak
indicates the molecular weight of fraction 21 at 13,938.668 kDa.

14

aggregation over a period of 24 hours was
recorded and revealed that the protein
aggregates both with and without NaCl at
approximately the same rate with no
significant difference (Fig. 14). Finally, the
interaction of CsgA with Aβ protein was
Figure 13: This graph of CD data shows a
minima at 200 nm indicating that CsgA has a
random coil structure.

also observed analyzing ThT fluorescence
and gel electrophoresis on the co-incubations
of the two proteins at different

stoichiometries (Fig. 15). As expected, it was observed that Aβ begins aggregation at
around the 10-hour mark (blue
triangles; Fig. 15). Notably, the
presence of CsgA inhibits the
aggregation of Aβ in all
stochiometries. The CsgA control
showed no aggregation within the
experimental time frame. These data
suggest a strong influence of CsgA on

Figure 14: This ThT (Thioflavin-T fluorescence)
graph shows aggregation of CsgA both with (black)
and without (red) the presence of NaCl.

Aβ aggregation and provides a molecular foundation for the effect of bacteria on AD.

15

Figure 15: ThT fluorescence data on the interaction between
CsgA with Aβ and how their aggregation is affected. Aβ was
kept constant at 10 μM while 5 and 10 μM CsgA was used.
The control CsgA corresponds to 10 μM.
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DISCUSSION AND CONCLUSION
Protein aggregation of amyloidogenic proteins is becoming increasingly relevant
as one of the hallmarks of neurodegenerative diseases. There is also growing evidence of
interactions between proteins of the gut microbiome and amyloidogenic neuronal proteins
via interplay between metabolic byproducts of symbiotic gut microbiomes and influence
on neurotransmitters. Throughout the course of this project, Curli fibril forming CsgA
protein purification protocol was standardized with intentions of isolating the protein to
observe its interactions with other amyloidogenic proteins and biophysical components.
The standardized purification process was time-consuming, as initial purifications yielded
insignificant amounts of impure protein. Each unsuccessful purification provided further
insight to how the protocol could be optimally modified. Through Ni(II)-affinity
purification with an Ni-NTA column and HPLC, purified CsgA was able to be obtained
in amounts substantial enough for testing with ThT fluorescence and CD spectroscopy in
the presence of NaCl and Aβ protein.
CD observations of CsgA revealed that the protein assumed a random coil
structure after aggregation over 24 hours. CsgA was seen to aggregate in the presence of
NaCl. Observations of ThT fluorescence of CsgA in the presence of and without NaCl
revealed that NaCl had no significant effect on CsgA aggregation. The aggregation time
remained relatively the same. However, when ThT fluorescence was observed for the
interactions between Aβ and CsgA, significant results were presented. The CsgA control
showed no signs of aggregation. The Aβ control was seen to begin aggregation around 10
hours, but in the presence of CsgA, Aβ did not aggregate. The CsgA amino acid sequence
contains 10 negatively charged residues at pH 7.2, and the Aβ amino acid sequence
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contains 6 negatively charged residues along with a large dissemination of hydrophobic
residues that are involved in its aggregation. It is hypothesized that the repulsions
between the proteins’ negatively charged molecules interfere with the ability of Aβ to
aggregate via the synergistic interactions between its negatively charged residues and
hydrophobic residues. Further approaches to this study could use biophysical methods to
investigate and test this hypothesis further.
Largely developing evidence of gut microbiota being linked to neurodegenerative
diseases emphasizes further implications for studies of CsgA and its interactions with
amyloidogenic neuronal proteins like Aβ. Knowing how proteins like CsgA interact with
other biophysical components to induce neurodegeneration contribute to understanding,
treatment, and prevention of neurodegenerative diseases. Studies like these provide
further evidence of the gut-brain axis and can ultimately provide insight into just how
influential gut microbiomes are on other essential parts of the body.
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